• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ANGO

ANGO

AngioDynamics, Inc.

NASDAQHealthcareMedical - Instruments & SuppliesUS

USD11.20

+0.22 (+2.00%)

Rating:D+

Company Profile

CEO

James C. Clemmer

IPO Date

2004-06-01

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Exchange

NASDAQ

Country

US

Market Metrics

Open

$11.07

Prev. Close

$10.98

Day Low

$10.90

Day High

$11.21

52W Low

$8.36

52W High

$13.99

Market Cap

$0.46B

Volume

0.29M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

42.0%

Avg Negative

3.7%

Avg Neutral

54.5%

News Feed

Why Is AngioDynamics (ANGO) Up 2.3% Since Last Earnings Report?

Zacks Investment Research·8/12/2021·↓ negative

After Beating Estimates, Is This Little-Known Medical Device Company a Buy?

The Motley Fool·7/18/2021·↑ positive

AngioDynamics (ANGO) Q4 Earnings Match Estimates, Revenues Top

Zacks Investment Research·7/14/2021·↑ positive

AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q4 2021 Results - Earnings Call Transcript

Seeking Alpha·7/13/2021·↓ negative

AngioDynamics Breaks-Even In FY21, Issues Mixed Forecasts For FY22

Benzinga·7/13/2021·↑ positive

AngioDynamics Announces Details for Investor & Technology Day on July 13, 2021

Business Wire·7/8/2021·↑ positive

AngioDynamics to Report Fiscal 2021 Fourth Quarter and Full-Year Financial Results and Host Investor & Technology Day on July 13, 2021

Business Wire·6/24/2021·↑ positive

AngioDynamics (ANGO) Hits New 52-Week High: What's Driving It?

Zacks Investment Research·6/22/2021·↑ positive

AngioDynamics (ANGO) Receives FDA Nod for AlphaVac System

Zacks Investment Research·6/9/2021·↑ positive

AngioDynamics (ANGO) Up 4.3% Since Last Earnings Report: Can It Continue?

Zacks Investment Research·4/29/2021·↓ negative